CEL logo

Celadon Pharmaceuticals Plc Stock Price

AIM:CEL Community·UK£9.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

CEL Share Price Performance

UK£0.13
0.09 (197.78%)
UK£0.13
0.09 (197.78%)
Price UK£0.13

CEL Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slight with imperfect balance sheet.

4 Risks
1 Reward

Celadon Pharmaceuticals Plc Key Details

UK£130.0k

Revenue

UK£91.0k

Cost of Revenue

UK£39.0k

Gross Profit

UK£5.3m

Other Expenses

-UK£5.2m

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.076
30.00%
-4,024.62%
1.3%
View Full Analysis

About CEL

Founded
2018
Employees
27
CEO
James Short
WebsiteView website
celadonpharma.com/

Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.

Recent CEL News & Updates

Recent updates

No updates